[Immune response to influenza vaccination among peritoneal dialysis patients].
The influenza vaccination is considered useful in preventing influenza and its complications, but its efficacy is variable especially in uremia. The humoral efficacy in a group of 15 patients in peritoneal dialysis treatment has been evaluated. Antibody responses were measured before vaccination and at time intervals of 1-4 months after vaccination. A good response to viruses A (A/H3N2/Johannesburg 33/94, A/H1N1/Singapore 6/86), respectively 80% and 66.7% and an attenuated response (20%) to virus B (B/Beijing 184/93) was observed. For viruses A, the "non responders" were elder patients with a low count of lymphocytes. For virus B it is suggested that the low response is perhaps related to variable effectiveness of vaccine.
Dogliani
M
M
Servizio di Nefrologia e Dialisi, USL 6 Ospedale di Ciriè.
Fidelio
T
T
Scalzo
B
B
Iacono
G
G
Bagatella
M
M
Piro
F
F
D000328:Adult; D000368:Aged; D000914:Antibodies, Viral / Q000096:biosynthesis*; D005260:Female; D006801:Humans; D009980:Influenza A virus / Q000276:immunology*; D009981:Influenza B virus / Q000276:immunology*; D007252:Influenza Vaccines / Q000276:immunology*; D007676:Kidney Failure, Chronic / Q000276:immunology* / Q000628:therapy; D018655:Lymphocyte Count; D008297:Male; D008875:Middle Aged; D010530:Peritoneal Dialysis; D012709:Serum Albumin / Q000032:analysis
D000914:Antibodies, Viral; D007252:Influenza Vaccines; D012709:Serum Albumin
Risposta immune alla vaccinazione antiinfluenzale nei pazienti in dialisi peritoneale.